# Question 13

**Type:** Genomic Alteration Frequencies

**Question:** What percentage of patients in the MSK-CHORD Study have at least one TP53 mutation?

**Answer:**

## Results

In the **MSK-CHORD Study (MSK, Nature 2024)**:

- **Total patients**: 24,950
- **Patients with at least one TP53 mutation**: 13,105
- **Percentage**: **52.53%**

This means that more than half of the patients in the MSK-CHORD study have at least one TP53 mutation, which is consistent with TP53 being one of the most commonly mutated genes in cancer.

---

## Model Information
**Model:** anthropic:claude-sonnet-4-5-20250929
**Provider:** Anthropic
**Max Tokens:** 4096

---

*Generated on 2026-01-28 20:37:24*